Evaluating Treatments for Amyotrophic Lateral Sclerosis
Release Date: 02/17/2025
Treatment of Complicated Staphylococcus aureus Bacteremia
JAMA Author Interviews
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of...
info_outline
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms
JAMA Author Interviews
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content:
info_outline
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
JAMA Author Interviews
Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content:
info_outline
Life Support and Outcomes in Patients Admitted to Intensive Care Units
JAMA Author Interviews
Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University...
info_outline
Increases in Invasive Group A Streptococcal Infections
JAMA Author Interviews
The incidence of invasive group A streptococcal infections has risen in the US. Similar observations have been reported in other parts of the world. Authors Joshua Osowicki, MBBS, PhD, of Murdoch Children’s Research Institute and Theresa...
info_outline
Preventive Health Care Among Adults Eligible for Lung Cancer Screening
JAMA Author Interviews
Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang,...
info_outline
Cardiac Arrests During Long-Distance Running: What’s Changed?
JAMA Author Interviews
Despite increased participation in US long-distance running races, cardiac arrest incidence remains stable. Authors Jonathan Kim, MD, MSc, of Emory University, and Aaron Baggish, MD, of the University of Lausanne Switzerland, discuss the...
info_outline
Inhaled Sedation With Sevoflurane for Acute Respiratory Distress Syndrome (ARDS)
JAMA Author Interviews
ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor...
info_outline
New FDA Pulse Oximetry Guidance: Strengths and Weaknesses
JAMA Author Interviews
The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip...
info_outline
Combining CAC Score With Treatment on Plaque Progression in Familial Coronary Artery Disease
JAMA Author Interviews
The CAUGHT-CAD randomized clinical trial sought to determine whether a CAC score-informed strategy could slow the progression of coronary plaque volume. Author Thomas H. Marwick of the Baker Heart & Diabetes Institute joins JAMA...
info_outlineThe HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD.
Related Content: